Karoline V. Gleixner
Ludwig Boltzmann Institute for Cardiovascular Research(AT)Medical University of Vienna(AT)
Publications by Year
Research Areas
Mast cells and histamine, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Eosinophilic Disorders and Syndromes, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects(2005)246 cited
- → High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia(2011)187 cited
- → Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis(2020)172 cited
- → Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)(2012)154 cited
- → Emicizumab for the treatment of acquired hemophilia A(2020)143 cited
- → International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study(2019)136 cited